GGrantIndex
← Leaderboards

Anna Greka

Brigham And Women'S Hospital

$12,512,557
Attributed
$12,512,557
Total exposure
5
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.5M · FY201025
$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,512,557 · 5

By mechanism

R01$8,835,991 · 2
TL1$2,893,038 · 1
K08$633,528 · 1
R56$150,000 · 1

Top collaborators

No co-investigators on record.

Most similar at Brigham And Women'S Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Kidney Diseases

Research focus

Kidney DiseasesInjuryPathway InteractionsMediatingPodocyteSignal TransductionMutationPublishingIon ChannelPreventProteinuriaFocal Segmental GlomerulosclerosisBaseKidney FailureIn VivoKidneyMolecularAreaAffectFoot ProcessDisease ProgressionNovel TherapeuticsCessation Of LifeIn Vitro

Grant awards (31)

Training Core$1,377,456
TL1 · FY2025 · DK · contact PI
Mechanisms of disrupted homeostasis and kidney injury$565,177
R01 · FY2025 · DK · contact PI
Molecular mechanisms of podocyte injury in FSGS$400,838
R01 · FY2025 · DK · contact PI
Training Core$148,523
TL1 · FY2025 · DK · contact PI
Training Core$1,367,059
TL1 · FY2024 · DK · contact PI
Mechanisms of disrupted homeostasis and kidney injury$565,177
R01 · FY2024 · DK · contact PI
Molecular mechanisms of podocyte injury in FSGS$390,369
R01 · FY2024 · DK · contact PI
Molecular mechanisms of podocyte injury in FSGS$407,671
R01 · FY2022 · DK · contact PI
Ion-channel targeted therapy for progressive kidney diseases$384,750
R01 · FY2022 · DK · contact PI
Molecular mechanisms of podocyte injury in FSGS$412,574
R01 · FY2021 · DK · contact PI
Ion-channel targeted therapy for progressive kidney diseases$384,750
R01 · FY2021 · DK · contact PI
Molecular mechanisms of podocyte injury in FSGS$411,127
R01 · FY2020 · DK · contact PI
Ion-channel targeted therapy for progressive kidney diseases$384,750
R01 · FY2020 · DK · contact PI
Molecular mechanisms of AT1R signaling in FSGS$386,063
R01 · FY2019 · DK · contact PI
Ion-channel targeted therapy for progressive kidney diseases$384,750
R01 · FY2019 · DK · contact PI
Molecular mechanisms of AT1R signaling in FSGS$386,063
R01 · FY2018 · DK · contact PI
Role of TRPC5 channel inhibition in the treatment of glomerular disease$366,308
R01 · FY2018 · DK · contact PI
Molecular mechanisms of AT1R signaling in FSGS$386,063
R01 · FY2017 · DK · contact PI
Role of TRPC5 channel inhibition in the treatment of glomerular disease$366,308
R01 · FY2017 · DK · contact PI
Molecular mechanisms of AT1R signaling in FSGS$386,063
R01 · FY2016 · DK · contact PI
Role of TRPC5 channel inhibition in the treatment of glomerular disease$366,308
R01 · FY2016 · DK · contact PI
Molecular mechanisms of AT1R signaling in FSGS$385,338
R01 · FY2015 · DK · contact PI
Role of TRPC5 channel inhibition in the treatment of glomerular disease$366,148
R01 · FY2015 · DK · contact PI
Role of TRPC5 channel inhibition in the treatment of glomerular disease$365,200
R01 · FY2014 · DK · contact PI
Molecular mechanisms of AT1R signaling in FSGS$352,479
R01 · FY2014 · DK · contact PI
Molecular mechanisms of AT1R signaling in FSGS$31,717
R01 · FY2014 · DK · contact PI
TRPC channels in proteinuric kidney disease$158,382
K08 · FY2013 · DK · contact PI
TRPC channels in proteinuric kidney disease$158,382
K08 · FY2012 · DK · contact PI
TRPC-mediated calcium signaling in podocytes$150,000
R56 · FY2012 · DK · contact PI
TRPC channels in proteinuric kidney disease$158,382
K08 · FY2011 · DK · contact PI
TRPC channels in proteinuric kidney disease$158,382
K08 · FY2010 · DK · contact PI